Clinical development of gefitinib in non-small-cell lung cancer and the Iressa® survival evaluation in lung cancer trial

Nancy Price, Chandra P. Belani

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)214-216
Number of pages3
JournalClinical Lung Cancer
Volume6
Issue number4
DOIs
StatePublished - Jan 2005

Fingerprint

Non-Small Cell Lung Carcinoma
Lung Neoplasms
gefitinib

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

@article{ea6a4ed9193e4a739fa5d376418cd9bd,
title = "Clinical development of gefitinib in non-small-cell lung cancer and the Iressa{\circledR} survival evaluation in lung cancer trial",
author = "Nancy Price and Belani, {Chandra P.}",
year = "2005",
month = "1",
doi = "10.1016/S1525-7304(11)70473-9",
language = "English (US)",
volume = "6",
pages = "214--216",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "4",

}

Clinical development of gefitinib in non-small-cell lung cancer and the Iressa® survival evaluation in lung cancer trial. / Price, Nancy; Belani, Chandra P.

In: Clinical Lung Cancer, Vol. 6, No. 4, 01.2005, p. 214-216.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical development of gefitinib in non-small-cell lung cancer and the Iressa® survival evaluation in lung cancer trial

AU - Price, Nancy

AU - Belani, Chandra P.

PY - 2005/1

Y1 - 2005/1

UR - http://www.scopus.com/inward/record.url?scp=14644407452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14644407452&partnerID=8YFLogxK

U2 - 10.1016/S1525-7304(11)70473-9

DO - 10.1016/S1525-7304(11)70473-9

M3 - Article

C2 - 15694012

AN - SCOPUS:14644407452

VL - 6

SP - 214

EP - 216

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - 4

ER -